Salvarani, Carlo

Trial of tocilizumab in giant-cell arteritis

Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., et al. (2017) · New England Journal of Medicine

Vasculitis and related conditionsRheumatoid Arthritis Research and Therapies

Cited by 1,386

Polymyalgia rheumatica and giant-cell arteritis

Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet

Vasculitis and related conditionsOtitis Media and Relapsing Polychondritis

Cited by 767

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases

Spondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis

Cited by 390

Relationship between Plasma Profiles of Oxytocin and Adrenocorticotropic Hormone during Suckling or Breast Stimulation in Women

Chiodera, P., Salvarani, C., Bacchi-Modena, A., Spallanzani, R., Cigarini, C., Alboni, A., Gardini, E., & Coiro, V. (2008) · Hormone Research

Neuroendocrine regulation and behaviorStress Responses and Cortisol

Cited by 154